Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 763 of 6351
-
Can new pills tame high blood pressure?
Disease control CompletedThe purpose of this study is to evaluate the efficacy and safety of AD-224
Phase 3 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New hope for scleroderma lung disease: major trial underway
Disease control Recruiting nowThe goal of this clinical trial is to test efficacy of different investigational products (IPs) compared with placebo on the change from baseline to the end of the treatment period at Week 52 in lung capacity in participants with Interstitial Lung Disease Secondary to Systemic Sc…
Phase 2 • Sponsor: Scleroderma Research Foundation, Inc. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could a simple blood test finally diagnose TB in kids?
Diagnosis Recruiting nowPediatric tuberculosis (TB) continues to pose diagnostic challenges in low- and middle-income countries with high rates of TB disease, due to the well-described impact of paucibacillary disease in children, and current TB culture and polymerase-chain reaction tests are of limited…
Sponsor: Tulane University • Aim: Diagnosis
Last updated Jun 26, 2026 13:32 UTC
-
New drug shows promise for tough lymphomas in early trial
Disease control OngoingPrimary Objective To evaluate the preliminary efficacy of Purinostat Mesylate for Injection in patients with relapsed or refractory Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL). Secondary Objectives 1. To evaluate the safety and tolerability of Purinos…
Phase 2 • Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New trial tests if early surgery saves lives in aortic dissection
Disease control Recruiting nowThe goal of this clinical trial is to determine whether an upfront invasive strategy of TEVAR plus medical therapy reduces the occurrence of a composite endpoint of all-cause death or major aortic complications compared to an upfront conservative strategy of medical therapy with …
Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can a computer program teach the brain to read social cues?
Disease control CompletedDrug use, substance-related disorders (SUD), other addictive behaviors, or, from a broader perspective, dual pathology, are problems of enormous socio-health impact that still require a great research effort to improve diagnostic and therapeutic procedures employed in healthcare …
Sponsor: Fundacin Biomedica Galicia Sur • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Triple threat: new combo therapy targets rare rectal cancer
Disease control Recruiting nowThe goal of this clinical trial is to learn if PD-1 monoclonal antibody combined with radical chemoradiotherapy works to treat rectal squamous cell carcinoma (rSCC). lt will also learn about the safety of the regime. The main questions it aims to answer are: Does PD-1 monoclonal…
Phase 2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can plasma transfusion and blood filtering save lives in leptospirosis?
Disease control Recruiting nowThe goal of this clinical trial is to learn if complement factor I (CFI) works to predict development of complications in participants with leptospirosis. It will also learn if plasma transfusion, hemoperfusion, and extracorporeal membrane oxygenation works to treat participants …
Phase 2 • Sponsor: National Kidney and Transplant Institute, Philippines • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Does real-time glucose tracking before surgery cut complications? a massive trial puts it to the test.
Disease control CompletedThe goal of this multi-center, pragmatic, randomized controlled trial is to assess the effectiveness of continuous glucose monitoring (CGM) compared with conventional monitoring in enhancing surgical outcomes for diabetic patients. The main questions it aims to answer are: * To …
Sponsor: Beijing Tsinghua Chang Gung Hospital • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Does when you eat carbs and protein reshape blood sugar control?
Disease control OngoingThe overall aim is to identify the dietary pattern for prevention and treatment of type 2 diabetes. The specific aim of this pilot project is to compare effects of two diets with different diurnal distribution of carbohydrates and protein on the glucose metabolism in subjects wit…
Sponsor: German Institute of Human Nutrition • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New weekly shot could help control blood sugar in type 2 diabetes
Disease control CompletedThe purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes and inadequate glycemic control. The study will last about 11 months and may include up to 11 visits.
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New drug targets Hard-to-Treat breast cancers
Disease control CompletedThe primary purpose of the Dose Optimization (Part 1) of this study is to assess the safety and tolerability of BB-1701 and to determine the recommended dose (RD) of BB-1701 for Dose Expansion (Part 2). The primary purpose of Dose Expansion (Part 2) is to assess the antitumor act…
Phase 2 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Five-Minute phone games could sharpen child abuse detection
Knowledge-focused OngoingThis project investigates whether a multi-faceted strategy involving iLookOut's evidence-based Core Training plus an innovative follow-up Micro-Learning can promote knowledge retention and change behavior among early childhood professionals (ECPs) with regard to child abuse and i…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
A new device may fix underbites without the facemask
Disease control CompletedThis clinical study compared two orthopedic treatment approaches for growing patients with skeletal Class III malocclusion associated primarily with maxillary deficiency: the Ertty Gap III appliance and facemask therapy. Participants assigned to active treatment received either E…
Sponsor: Ankara University • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New drug trial offers hope for rare brain disease in boys
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION356.
Phase 1 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a statin right after a stroke stop a second one?
Disease control Recruiting nowAlong with the current clinical trial, the impact of adding atorvastatin or rosuvastatin in the first 24 hours on the clinical outcomes of first-ever small vessel stroke patients treated with clopidogrel and aspirin assessed through NIHSS, mRS, and possible adverse effects.
Phase 3 • Sponsor: Kafrelsheikh University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can 5-Minute phone games sharpen child abuse detection?
Knowledge-focused OngoingThis proposed randomized controlled trial will examine whether gamified micro-learning is a feasible and effective way to promote long-term learning about child abuse and its reporting. After completing the interactive online learning program, iLookOut for Child Abuse, early chil…
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
New drug cocktail aims to outperform standard lung cancer therapy
Disease control Recruiting nowNon-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mortality worldwide, with poor survival prospects for metastatic disease. The purpose of this study is to evaluate the optimized dose, adverse events, and efficacy of livmoniplimab in combination wi…
Phase 2/3 • Sponsor: AbbVie • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a needle replace a machine? new study aims to simplify lifesaving iTTP treatment
Disease control Recruiting nowImmune thrombotic thrombocytopenic purpura (iTTP) is caused by a severe, autoantibody-mediated deficiency of ADAMTS13 leading to an accumulation of ultra-large von Willebrand factor multimers in plasma and finally to microthrombi in blood vessels. The current standard of care of …
Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Experimental CAR-T therapy takes on progressive MS
Disease control Recruiting nowA Study of Anti-CD19 Chimeric Antigen Receptor T Cell Therapy in Subjects with Non-relapsing and Progressive Forms of Multiple Sclerosis
Phase 1 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC